Share Twitter LinkedIn Facebook Email Ecaterina Dumbrava, MD of MD Anderson Cancer Center @MDAndersonNews discusses the phase I trial of COM701 presented at the virtual AACR 2020. Read here: https://www.clinicaltrials.gov/ct2/show/NCT03667716?term=NCT+03667716&draw=2&rank=1 Advertisement
Cell Therapy for Solid Tumors: Immunotherapy Biomarkers Anusha Kalbasi, MD MOASC [2023] Immunotherapy 2 Mins Read
O-RECIST, iRECIST, ImmunoPET: Assessing Treatment Response – Anna M. Wu, MD – MOASC [2023] Immunotherapy 1 Min Read